Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Mid-range Performer
1352.3000 23.60 (1.78%)
NSE Apr 06, 2026 15:31 PM
Volume: 328.7K
 

1352.30
1.78%
Geojit BNP Paribas
EBITDA rose 16.4% YoY to Rs. 179cr, and the margin expanded 140 basis points (bps) YoY to 27.2%, driven by sustained volume growth, network expansion and a favourable mix, combined with the efficient hub-and-spoke model and technology...
Dr. Lal Pathlabs Ltd. is trading below all available SMAs
More from Dr. Lal Pathlabs Ltd.
Recommended